HNB
LXRX icon

Huntington National Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History

Huntington National Bank’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-400
Closed -$5K – 1783
2018
Q2 		$5K Hold
400
– – ﹤0.01% 1444
2018
Q1 		$3K Buy
+400
New +$3.7K ﹤0.01% 1483
2016
Q4 		– Sell
-503
Closed -$9K – 1474
2016
Q3 		$9K Buy
+503
New +$8.1K ﹤0.01% 1260

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SGA
Sector Gamma AS Oslo, Norway $423M AUM 17.56% 1-Year Est. Return

Huntington National Bank's LXRX Position: Q3 2018 in Review

Huntington National Bank sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2018, closing a stake of 400 shares — an estimated $5K sold.

Huntington National Bank first reported a position in LXRX in Q3 2016 and held it in 3 quarters. The position peaked at $9K in Q3 2016. 119 funds tracked by Wall St. Rank hold LXRX as of Q3 2018.

  • Huntington National Bank reported no remaining Lexicon Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Huntington National Bank sold 400 Lexicon Pharmaceuticals shares in Q3 2018, an estimated $5K.
  • Huntington National Bank first reported a position in Lexicon Pharmaceuticals in Q3 2016 and held it in 3 quarters.
  • Huntington National Bank's Lexicon Pharmaceuticals position peaked at $9K in Q3 2016.
  • 119 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2018.

Based on Huntington National Bank's 13F filing for Q3 2018, filed 18 Oct 2018.